Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation
PrevAsPI-Obs
1 other identifier
observational
91
1 country
1
Brief Summary
Inhalation pneumonia (PI) is common in clinical practice but is rarely studied. For example, there are no data on the incidence of pneumonia after inhalation and risk factors or protective factors to develop one since it is known that anyone who inhaled does not necessarily develop an IP. There is no data on the benefit of treating inhalation by antibiotic therapy pre-emptively although this practice is common. In this context, this observational study wishes to take stock of the situation on the subject in order to determine what actions to implement to prevent IP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 18, 2016
CompletedFirst Submitted
Initial submission to the registry
March 31, 2017
CompletedFirst Posted
Study publicly available on registry
April 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedJune 16, 2026
June 1, 2026
6.3 years
March 31, 2017
June 15, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Calculate the annual incidence of PI, the incidence of PI in inhaled patients (in each subgroup), and analyze the risk factors by logistic regression, based on the number of patients hospitalized during the study period.
1 day
Study Arms (3)
Inhalation pneumonia
Proven inhalations
Suspected inhalations (coma + anamnesis)
Interventions
Calculate the annual incidence of PI, the incidence of PI in inhaled patients (in each subgroup), and analyze the risk factors by logistic regression, based on the number of patients hospitalized during the study period.
Eligibility Criteria
Observation of inhalations in medicine and resuscitation and collection of data likely to influence the emergence of an IP.
You may qualify if:
- In intensive care: Any intubated patient who presented:
- It is a coma with GCS ≤ 12 without VAS protection, whatever the duration
- Either a proven inhalation, defined by the presence in the VAS of gastric fluid or food
- Either a suspected inhalation, defined by the extrahospital anamnesis
- In medicine :
- Any wrong way (defined by a reflex cough when taking food)
- Coma without intubation, regardless of duration or depth
You may not qualify if:
- Patients with VAP
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens Picardie
Amiens, Picardie, 80054, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 31, 2017
First Posted
April 11, 2017
Study Start
November 18, 2016
Primary Completion
March 1, 2023
Study Completion
March 1, 2023
Last Updated
June 16, 2026
Record last verified: 2026-06